US FDA to study quantitative effectiveness information in DTC ads
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration is seeking comments on a study it intends to carry out on the presentation of quantitative effectiveness information to consumers in direct-to-consumer television and print advertisements for prescription drugs1. Comments must be submitted by 21 August.
You may also be interested in...
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
Global medtech alliance approves six new member associations
An emerging alliance of medical technology industry associations representing innovative companies that currently develop and manufacture 85% of the world's medical devices, diagnostics and equipment has approved the membership applications of six more associations, bringing the total number of members to 19.
US FDA scrutiny of DTC genetic tests continues
The US FDA's devices unit has written to three genetic testing companies warning them that they may be marketing their products and services without clearance by the agency.